ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0252

Role of Clinical and Laboratory Parameters in Differentiating Infection from Disease Flare in Febrile Patients of Systemic Juvenile Idiopathic Arthritis

Rajesh Kanumuri1, Suma Balan2, Vishal Marwaha2, Sajitha Krishnan2 and Pranav Chickermane2, 1Amrita Institute of Medical Sciences, Guntur, India, 2Amrita Institute of Medical Sciences, Kochi, India

Meeting: ACR Convergence 2021

Keywords: Fever, Infection, macrophage activation syndrome, Procalcitonin, systemic juvenile idiopathic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Fever is the most common presentation of systemic juvenile idiopathic arthritis (SJIA) and it is difficult to predict whether the fever is due to infection or underlying disease flare. This study has been undertaken to determine the role of clinical and laboratory parameters in differentiating infection and disease flare in febrile patients of SJIA, with particular reference to serum procalcitonin levels.

Methods: In this cross-sectional study, patients diagnosed with SJIA (as per ILAR classification criteria) who presented with fever (temperature ≥38oC) for more than ≥48 hours under the age of 16years between March 2018 to October 2019 were included. Blood samples for hemogram, acute phase reactants (ESR, C- Reactive protein and ferritin) procalcitonin levels were collected along with cultures of the respective body fluids at the time of presentation for the evaluation of fever. Patients were stratified into infection group and disease flare (with or without MAS) group. Febrile episodes were categorized as “Infection” based on their clinical profile along with body fluid evaluation & culture or tissue culture or serological assays or any imaging study suggestive of infection and their prompt response to antibiotics without hiking the immunosuppression. “Disease flare” group was defined as those patients with daily fever ≥38oC for ≥2 days in a diagnosed case of SJIA, without any laboratory evidence of infection and the prompt response to hike in immunosuppression. MAS was defined as per the EULAR/ACR 2016 classification criteria. The receiver operating characteristic (ROC) curve analysis was used to find out the respective cut-off values.

Results: A total of 52 visits of 25 patients were included. Twelve (23.1%) were in the infection group and 40 (76.9%) were in the disease flare group (27 were disease flare without MAS and 13 were disease flare with MAS). The mean (SD) & median (IQR) values of laboratory parameters including serum procalcitonin levels did not show any statistical significance in differentiating infection and disease flare groups, whereas clinical parameters like quotidian pattern of fever, evanescent maculopapular rash and joint symptoms showed statistical significance (p value: < 0.05). In patients with disease flare, cut-off values of procalcitonin ≥0.95ng/ml, CRP ≥103mg/L and ferritin ≥ 3842.5 ng/ml predicted MAS with good sensitivity and specificity (p value:< 0.05).

Conclusion: In our study none of the laboratory parameters including serum procalcitonin levels, were useful in differentiating infectious cause of fever from disease flare in febrile patients with SJIA. Serum procalcitonin levels were elevated even in the absence of infection in SJIA disease flare with MAS and a value of ≥0.95ng/ml was found to be a reliable predictor in identifying the MAS complicating SJIA. Presence of classical clinical features of SJIA are helpful in differentiating the disease flare from infection with high accuracy.

Image 1: Comparison of clinical manifestations with respect to infection and disease flare groups

Image 2: Comparison of lab parameters with respect to infection and disease flare groups

Image 3: Cut-off values of Procalcitonin, CRP and Ferritin in differentiating patients of disease flare with MAS and without MAS


Disclosures: R. Kanumuri, None; S. Balan, None; V. Marwaha, None; S. Krishnan, None; P. Chickermane, None.

To cite this abstract in AMA style:

Kanumuri R, Balan S, Marwaha V, Krishnan S, Chickermane P. Role of Clinical and Laboratory Parameters in Differentiating Infection from Disease Flare in Febrile Patients of Systemic Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/role-of-clinical-and-laboratory-parameters-in-differentiating-infection-from-disease-flare-in-febrile-patients-of-systemic-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-clinical-and-laboratory-parameters-in-differentiating-infection-from-disease-flare-in-febrile-patients-of-systemic-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology